Fractyl Health, Inc. (GUTS) Financials

GUTS Assets vs Liabilities

DateAssetsLiabilities
June 30, 2026 82.0 million 83.6 million
March 31, 2026 99.4 million 78.0 million
Dec. 31, 2025 121.4 million 111.9 million
Sept. 30, 2025 114.3 million 117.5 million

GUTS Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -15.9 million 2.5 million
March 31, 2026 -22.5 million 2.5 million
Dec. 31, 2025 -21.3 million 1.9 million
Sept. 30, 2025 -22.7 million 1.6 million

GUTS Net Income

No data available :(

GUTS Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 47.1 million 30.4 million 30.3 million
March 31, 2026 63.2 million 30.1 million 30.7 million
Dec. 31, 2025 81.5 million 30.6 million 26.0 million
Sept. 30, 2025 77.7 million 30.8 million 31.4 million

GUTS Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 158.6 million
March 31, 2026 158.5 million
Dec. 31, 2025 153.4 million
Sept. 30, 2025 64.7 million

GUTS Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 - 13.8 million 5.3 million -
March 31, 2026 - 15.6 million 5.2 million -
Dec. 31, 2025 3000 16.5 million 6.8 million -
Sept. 30, 2025 8000 17.5 million 5.2 million -

GUTS Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - -
March 31, 2026 - -
Dec. 31, 2025 - 279000
Sept. 30, 2025 - 290000

GUTS

Price: $1.55

52 week price:
0.38
4.57

Earnings Per Share: -0.91 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 64.5 million

Links: